/>

Pages

Sunday, September 2, 2018

NEWS 01 SEP 2018

 

NEWS FROM USA

ANDA Approvals     

DRUG

COMPANY

Corresponding RLD

Press release if available

Fenofibrate Tablets

Prinston

Tricor (Abbvie)

 

Lamivudine; Zidovudine Tablets

Macleods

Combivir (Viiv Healthcare)

 

Potassium Chloride

Solution

Novel lab

Potassium Chloride (Genus)

 

Isosorbide Mononitrate ER Tablets

Dexcel

N/A

 

Efavirenz Tablets

Aurobindo

Sustiva (BMS)

 

Potassium Chloride

Solution

Lupin

Potassium Chloride (Genus)

Link

 

NEW GENERICS LAUNCHES IN THE US

 

DRUG

COMPANY

Corresponding RLD

Press Release

Diphenoxylate Hydrochloride and Atropine Sulfate Tablets

Upsher smith lab

Lomotil (Pfizer)

Link

 

 

NEW PARA IV ANDA FILINGS

 

DRUG

Strength

Corresponding RLD

Filing date

Abiraterone Acetate Tablets

125 Mg

Yonsa

23 July 2018

Belinostat Injection

500 Mg/Vial

Beleodaq

03 July 2018

Budesonide And Formoterol Fumarate Dihydrate Metered Inhalation

80 Mcg/4.5 Mcg Per Inhalation And
160 Mcg/4.5 Mcg Per Inhalation

Symbicort

26 June 2018

Esomeprazole Magnesium DR For Oral Suspension

10 Mg

Nexium

06 July 2018

Vasopressin Injection

20 Units/Ml, 10 Ml

Vasostrict

29 June 2018

 

 

 

NEWS FROM EUROPE

Alnylam Receives Approval of ONPATTRO (patisiran) in Europe

European Commission approves Nucala (mepolizumab) for the treatment of children with severe asthma

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com


To receive weekly/monthly updates, write us at pharmacaption@gmail.com

No comments:

Post a Comment